Danaher (NYSE:DHR) had its price objective raised by research analysts at Argus from $100.00 to $115.00 in a report issued on Thursday, The Fly reports. The firm presently has a “buy” rating on the conglomerate’s stock. Argus’ target price points to a potential upside of 13.55% from the stock’s current price.
Other equities research analysts also recently issued research reports about the stock. Stifel Nicolaus upped their target price on shares of Danaher from $110.00 to $115.00 and gave the company a “buy” rating in a research note on Wednesday. Royal Bank of Canada reaffirmed a “hold” rating and issued a $98.00 target price on shares of Danaher in a research note on Wednesday. Cowen reaffirmed a “buy” rating and issued a $110.00 target price on shares of Danaher in a research note on Tuesday. Credit Suisse Group reaffirmed an “outperform” rating and issued a $105.00 target price (up previously from $99.00) on shares of Danaher in a research note on Wednesday. Finally, Morgan Stanley upped their target price on shares of Danaher from $103.00 to $110.00 and gave the company an “overweight” rating in a research note on Wednesday. One investment analyst has rated the stock with a sell rating, five have given a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the stock. The company presently has an average rating of “Buy” and a consensus target price of $100.13.
Danaher (NYSE DHR) opened at $101.28 on Thursday. Danaher has a twelve month low of $78.97 and a twelve month high of $104.82. The firm has a market cap of $70,673.48, a P/E ratio of 28.69, a P/E/G ratio of 2.21 and a beta of 1.02. The company has a quick ratio of 1.00, a current ratio of 1.43 and a debt-to-equity ratio of 0.39.
In other news, SVP Daniel Raskas sold 37,870 shares of the stock in a transaction on Thursday, November 16th. The shares were sold at an average price of $93.33, for a total transaction of $3,534,407.10. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 12.20% of the stock is owned by corporate insiders.
Several hedge funds have recently modified their holdings of DHR. GQG Partners LLC bought a new position in Danaher in the second quarter valued at $101,000. First Personal Financial Services grew its position in Danaher by 128.9% in the fourth quarter. First Personal Financial Services now owns 1,227 shares of the conglomerate’s stock valued at $114,000 after purchasing an additional 691 shares in the last quarter. Zions Bancorporation grew its position in Danaher by 118.3% in the third quarter. Zions Bancorporation now owns 1,231 shares of the conglomerate’s stock valued at $106,000 after purchasing an additional 667 shares in the last quarter. Resources Investment Advisors Inc. grew its position in Danaher by 661.2% in the fourth quarter. Resources Investment Advisors Inc. now owns 1,530 shares of the conglomerate’s stock valued at $142,000 after purchasing an additional 1,329 shares in the last quarter. Finally, Monetary Management Group Inc. grew its position in Danaher by 10.7% in the second quarter. Monetary Management Group Inc. now owns 1,550 shares of the conglomerate’s stock valued at $131,000 after purchasing an additional 150 shares in the last quarter. 76.16% of the stock is owned by institutional investors.
About Danaher
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
